LA
LKFT

LVW Advisors’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

LVW Advisors’s Portfolio LKFT Stock Details LKFT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-2,938
Closed -$226K – 226
2021
Q1 		$226K Buy
2,938
+466
+19% +$42.9K 0.04% 196
2020
Q4 		$245K Buy
2,472
+347
+16% +$42.4K 0.05% 187
2020
Q3 		$302K Buy
2,125
+334
+19% +$55.7K 0.07% 151
2020
Q2 		$353K Buy
1,791
+302
+20% +$62.5K 0.09% 123
2020
Q1 		$292K Buy
1,489
+134
+10% +$28.8K 0.08% 121
2019
Q4 		$280K Buy
+1,355
New +$250K 0.06% 147

Other funds holding LKFT

Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

LVW Advisors's LKFT Position: Q2 2021 in Review

LVW Advisors sold out of Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q2 2021, closing a stake of 2,938 shares — an estimated $226K sold.

LVW Advisors first reported a position in LKFT in Q4 2019 and held it in 6 quarters. The position peaked at $353K in Q2 2020. 108 funds tracked by Wall St. Rank hold LKFT as of Q2 2021.

  • LVW Advisors reported no remaining Lakefront Biotherapeutics American Depositary Shares position as of Q2 2021 after selling out during the quarter.
  • LVW Advisors sold 2,938 Lakefront Biotherapeutics American Depositary Shares shares in Q2 2021, an estimated $226K.
  • LVW Advisors first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q4 2019 and held it in 6 quarters.
  • LVW Advisors's Lakefront Biotherapeutics American Depositary Shares position peaked at $353K in Q2 2020.
  • 108 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q2 2021.

Based on LVW Advisors's 13F filing for Q2 2021, filed 15 Jul 2021.